Method of isolating cannabidiol from Cannabis sativa L. using supercritical fluid
The method of decarboxylation and supercritical fluid extraction under varying pressures enhances CBD extraction yield and purity to 99% without purification, suitable for pharmaceutical and cosmetic applications.
Patent Information
- Application Number
- KR1020230191099
- Authority / Receiving Office
- KR · KR
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2022-12-28
- Filing Date
- 2023-12-26
- Publication Date
- 2026-11-06
- Estimated Expiration
- 2043-12-26
AI Technical Summary
Existing methods for obtaining cannabidiol (CBD) from cannabis require a purification process, which reduces the extraction yield and purity, necessitating a method to achieve high-purity CBD without this additional step.
A method involving decarboxylation of cannabis followed by extraction under varying pressure conditions using supercritical fluids, specifically supercritical carbon dioxide, to enhance CBD content and purity without purification.
The method increases CBD extraction rate and purity to 99% or higher, enabling its use in pharmaceuticals and cosmetics with improved efficacy and reduced impurities.
Smart Images

Figure 112023145377815-PAT00002_ABST
Abstract
Description
Technology Field
[0001] The present invention relates to a method for obtaining cannabidiol from cannabis that can obtain cannabidiol with a purity of 99% or higher without performing the purification process that was previously performed. Background Technology
[0002] In traditional medical texts from China and Korea, hemp seeds with the hulls removed, known as *Majain* or *Hwamain*, have been used for constipation, diabetes, pain disorders, menstrual irregularities, skin diseases, and dysentery. Additionally, hemp leaves (*Macha*, *Mayeop*) have been recorded as being used as an anthelmintic, for hair protection, for asthma, for pain relief, anesthesia, and as a diuretic. Furthermore, records indicate that hemp roots were used to treat difficult childbirth and resolve blood stasis, hemp bark for bruises and open wounds, hemp flowers for paralysis and itching, and hemp powder was used for difficult childbirth, constipation, gout, phlegm, and insomnia, with the specific part of the plant used according to the symptoms.
[0003] Cannabis contains about 400 compounds, most of which are cannabinoids, terpenes, and phenolic compounds. Among these, cannabinoids, which are important natural components for medicine and pharmaceuticals, number about 90, and there are many components found only in cannabis.
[0004] Among the components of cannabis, substances known as psychoactive cannabinoids are tetrahydrocannabinol (THC), cannabinol (CBN), and cannabinodiol (CBDL), and cannabidiol (CBD) is known as a non-psychoactive component that exhibits physiological effects through various receptors in the human body, including adrenaline receptors and cannabinoid receptors.
[0005] In particular, while scientists were studying the mechanism of the psychoactive effects of cannabis, they discovered receptors in the brain to which cannabinoids selectively bind in 1988. This suggests that molecules similar to cannabinoids are also produced in our bodies, and these cannabinoid molecules are fatty acid-based neurotransmitters produced in localized areas of the brain, known as anandamide (Science, 1992, 258, 1946).
[0006] THC, the major active ingredient in medicinal cannabis, acts as an agonist with a strong affinity for CB1 receptors (distributed throughout the brain, including the cerebral cortex, hippocampus, cerebellum, and basal ganglia), and this is known to be the primary mechanism for its psychoactive effects. In contrast, numerous studies have revealed that CBD possesses beneficial effects, such as anti-inflammatory, antiepileptic, antiemetic, and anticancer properties. It is known to reduce side effects caused by THC (Current Pharmaceutical Design, 2012, 18, 4906; Bioorganic Medicinal Chemistry, 2015, 23, 1377) and inhibit the reabsorption and degradation of the endogenous cannabinoid anandamide through antagonism against CB1 and CB2 receptor agonists (which are primarily distributed in peripheral tissues such as macrophages, bone marrow, lungs, pancreas, and smooth muscle, and are closely related to the immune system), while simultaneously acting as an agonist for serotonin receptors (Neurochemcal Research, 2005, 30, 1037).
[0007] In addition, research on the pharmacological mechanisms of cannabis components is being actively conducted, with studies revealing that cannabichromene, a cannabis component, has anti-inflammatory, sedative, and antifungal effects, and that CBN helps improve immune function by binding to CB2 receptors rather than CB1 receptors (Frontiers in Plant Science 2016, 7, 19).
[0008] Extensive and active research is currently underway in the United States, including clinical trials for Epidiolex, a liquid drug with CBD as its main ingredient approved by the Food and Drug Administration (FDA), for pediatric epilepsy, and for Cannador (THC:CBD=2:1), a cannabis extract rather than a single CBD drug, for multiple sclerosis and severe chronic pain.
[0009] Therefore, there is a need for technology to increase the extraction yield and raise the CBD content of CBD, which is a non-psychotropic component among the major pharmaceutical components of cannabis. Prior art literature
[0010] Republic of Korea Published Patent No. 2021-0060410 United States Published Patent No. 2004-0033280 The problem to be solved
[0011] The objective of the present invention is to provide a method for obtaining cannabidiol with a purity of 99% or higher without performing the purification process that was previously performed. means of solving the problem
[0012] The method for obtaining cannabidiol from cannabis according to the present invention for achieving the above-mentioned purpose may include: (A) a step of decarboxylating cannabis; and (B) a step of extracting the decarboxylated cannabis by increasing the pressure from 100 bar to 200 bar and then lowering the pressure from 200 bar to 100 bar under a supercritical fluid.
[0013] In step (A) above, decarboxylation can be performed at 100 to 150 ℃ for 120 to 240 minutes, preferably at 115 to 130 ℃ for 140 to 240 minutes.
[0014] In step (B) above, the pressure conditions under the supercritical fluid may be repeated as follows: (a) maintaining at 100 bar for 50 to 80 minutes; (b) increasing the pressure maintained at 100 bar to 200 bar; (c) decreasing the pressure to 100 bar when it reaches 200 bar; and (d) maintaining at 100 bar when it reaches 100 bar for 50 to 80 minutes and then increasing the pressure back to 200 bar.
[0015] The above voltage boosting can be performed at a rate of 2 to 5 bar / min, respectively.
[0016] The above pressure reduction may be to immediately lower the pressure from 200 bar to 100 bar.
[0017] The above voltage boosting can be performed for 30 to 40 minutes.
[0018] The extraction time under supercritical fluid under the above pressure conditions may be 4 to 8 hours.
[0019] The above supercritical fluid may be one selected from the group consisting of supercritical carbon dioxide, supercritical ethane, supercritical propane, supercritical butane, supercritical pentane, supercritical hexane, supercritical heptane, supercritical dimethyl ether, supercritical tetrafluoromethane, supercritical difluoromethane, and supercritical fluoroethane.
[0020] After step (B) above, (C) a step of dewaxing the extract obtained with the supercritical fluid; and (D) a step of crystallizing the dewaxed extract to obtain cannabidiol may be added.
[0021] The purity of the crystallized cannabidiol above may be 99.0 to 100%. Effects of the invention
[0022] The method for obtaining cannabidiol from hemp according to the present invention can increase the cannabidiol (CBD) content and extraction rate in the extract by performing extraction while varying the pressure conditions under a supercritical fluid.
[0023] In particular, the present invention enables the production of high-purity cannabidiol (CBD) by reducing the content of impurities in the extract without performing the purification process used in the past.
[0024] Accordingly, the above cannabidiol (CBD) can be used in pharmaceuticals and quasi-pharmaceuticals for antiepileptic, neuroprotective, vasodilating, anticancer, anti-inflammatory, antidiabetic, antibacterial, analgesic, osteoporotic, immune, or antiemetic effects.
[0025] In addition, the above cannabidiol (CBD) can be used in general cosmetics or functional cosmetics with antioxidant or anti-inflammatory functions. Brief explanation of the drawing
[0026] Figure 1 is a graph showing pressure conditions for extraction under a supercritical fluid according to an embodiment of the present invention. FIG. 2 is a graph showing the results of measuring the extracts prepared according to Example 1 and Comparative Examples 1 to 3 of the present invention using a spectrophotometer. FIG. 3 is a chromatogram showing the purity of cannabidiol after crystallization of extracts prepared according to Example 1 and Comparative Examples 1 to 3 of the present invention. Specific details for implementing the invention
[0027] The present invention relates to a method for obtaining cannabidiol from cannabis that can obtain cannabidiol with a purity of 99% or higher without performing the purification process that was previously performed.
[0028] Conventionally, in order to obtain cannabidiol from hemp, it must be processed in the order of decarboxylation, extraction, dewaxing, purification, and crystallization, but the present invention can obtain high-purity cannabidiol even when processed in the order of decarboxylation, extraction, dewaxing, and crystallization.
[0029] In other words, the present invention allows for obtaining high-purity cannabidiol with a high yield without performing a purification process by processing the extraction process in a manner different from the conventional method.
[0031] Hereinafter, the present invention will be described in detail.
[0032] The method for obtaining cannabidiol of the present invention may include (A) a step of decarboxylating cannabis; and (B) a step of extracting the decarboxylated cannabis under a supercritical fluid, comprising a process of increasing the pressure from 100 bar to 200 bar and then decreasing the pressure from 200 bar to 100 bar. In addition, after the step (B), (C) a step of dewaxing the extract extracted with the supercritical fluid; and (D) a step of crystallizing the dewaxed extract to obtain cannabidiol (CBD) may be further included.
[0033] First, in the step (A), cannabis is decarboxylated.
[0034] The cannabis Cannabis sativa L. ) refers collectively to Cannabis sativa subspecies sativa including cannabis chemovars and variants thereof, varieties var. indica and var. kafiristanica, Cannabis sativa subspecies indica, Cannabis sativa subspecies ruderalis, and genetically crossed, self-crossed or hybrid plants thereof, which are annual plants of the genus Cannabis in the family Cannabaceae that have been widely cultivated in tropical and temperate regions centered on Central Asia for 12,000 years, including wild hemp, and contain various types of cannabinoid compounds known as medicinal and pharmaceutical components.
[0035] The cannabis contains cannabidiolic acid (CBDA), and converts the cannabidiolic acid (CBDA) into cannabidiol (CBD) through decarboxylation.
[0036] The decarboxylation of the present invention is performed at 100 to 150°C, preferably 115 to 130°C, for 120 to 240 minutes, preferably 140 to 240 minutes. If the temperature and time during decarboxylation fall outside the above ranges, the conversion rate from cannabidiol acid (CBDA) to cannabidiol (CBD) may be significantly low. In particular, if the temperature exceeds the above upper limit during decarboxylation, decomposition may occur during the process of conversion to cannabidiol (CBD) by heating, causing the conversion rate to drop sharply.
[0037] Next, in step (B), the decarboxylated cannabis can be extracted by including a process of increasing the pressure from 100 bar to 200 bar under a supercritical fluid and then lowering the pressure from 200 bar to 100 bar.
[0038] The present invention enables the extraction rate of cannabidiol (CBD) to be further increased and the impurity content to be lowered by processing under supercritical fluid conditions while varying the pressure conditions, thereby obtaining high-purity cannabidiol (CBD).
[0039] The above pressure conditions are performed by repeating the following steps: (a) maintaining the decarboxylated cannabis at 100 bar for 50 to 80 minutes under a supercritical fluid; (b) increasing the pressure maintained at 100 bar to 200 bar; (c) decreasing the pressure to 100 bar when it reaches 200 bar; and (d) maintaining the pressure for 50 to 80 minutes after it reaches 100 bar, and then increasing the pressure back to 200 bar.
[0040] Specifically, the pressure is maintained at 100 bar for 50 to 80 minutes, preferably 60 to 70 minutes (Step (a)), then the pressure is increased from 100 bar at a rate of 2 to 5 bar / min, preferably 3 to 4 bar / min, for 30 to 40 minutes to reach 200 bar (Step (b)), then the pressure is immediately reduced from 200 bar to 100 bar to lower the pressure (Step (c)), and once the pressure is reduced to 100 bar, the pressure is maintained for 50 to 80 minutes, preferably 60 to 70 minutes, and then the process of increasing the pressure back to 200 bar is repeated to perform extraction for a total of 4 to 8 hours, preferably 4 to 6 hours. The "immediately" time when reducing the pressure from 200 bar to 100 bar is 1 to 2 minutes.
[0041] As in the present invention, when extraction is performed under constant pressure rather than varying pressure conditions under supercritical fluid, there is a problem that a purification process is required due to the high content of impurities. When undergoing the purification process, the extraction rate of cannabidiol (CBD) may be further reduced.
[0042] Steps (a) through (c) above constitute one cycle. When maintaining pressure at 100 bar after one cycle ends (step (d)), if the pressure is maintained for a different time than in step (a), a large amount of impurities may be generated, so it is desirable to maintain the same time in step (a).
[0043] In addition, if the pressure is maintained at 200 bar instead of 100 bar in step (a) above, a large amount of impurities may be contained; if the time is less than the lower limit when maintaining the pressure at 100 bar, the extraction rate of cannabidiol (CBD) may decrease, and if it exceeds the upper limit, the extraction rate of cannabidiol (CBD) may decrease and a large amount of impurities may be contained.
[0044] In addition, if the pressure is maintained at 200 bar instead of being lowered to 100 bar in step (c) above, almost all of the extract may be filled with impurities, and if the pressure is lowered gradually rather than immediately to 100 bar, the extract may contain more than 80% by weight of impurities.
[0045] In addition, if the speed during pressure increase is below the lower limit mentioned above, a large amount of impurities may be generated, and if it exceeds the upper limit mentioned above, the extraction rate of cannabidiol (CBD) is lowered and impurities may also be generated.
[0046] In addition, if the processing time during pressure increase is less than the lower limit mentioned above, a large amount of impurities may be generated, and if it exceeds the upper limit mentioned above, the extraction rate of cannabidiol (CBD) may be very low.
[0047] When extraction is performed under supercritical fluid conditions with varying pressure conditions according to step (B) of the present invention, if the total extraction time is less than the lower limit, the desired extraction rate of cannabidiol (CBD) may not be obtained, and if it exceeds the upper limit, a large amount of impurities may be generated.
[0048] The above supercritical fluid is not particularly limited as long as it can yield cannabidiol, but preferably it may be one selected from the group consisting of supercritical carbon dioxide, supercritical ethane, supercritical propane, supercritical butane, supercritical pentane, supercritical hexane, supercritical heptane, supercritical dimethyl ether, supercritical tetrafluoromethane, supercritical difluoromethane, and supercritical fluoroethane, and more preferably it may be supercritical carbon dioxide.
[0049] Next, in step (C), the extract obtained with the supercritical fluid is dewaxed with alcohol, and then in step (D), the dewaxed extract is crystallized to obtain cannabidiol (CBD).
[0050] The above dewaxing and crystallization methods are not particularly limited as long as they are used in a method for obtaining cannabidiol (CBD).
[0051] The purity of the crystallized cannabidiol is 99.0 to 100%, and the yield of cannabidiol (CBD) is 40 to 60%.
[0053] Hereinafter, preferred embodiments are presented to aid in understanding the present invention; however, the following embodiments are merely illustrative of the invention, and it is obvious to those skilled in the art that various changes and modifications are possible within the scope and spirit of the invention, and that such variations and modifications fall within the scope of the appended claims.
[0054] [Measurement of Decarboxylation Efficiency]
[0055] Preparation Examples 1 to 9. 105 ℃
[0056] The dried and ground cannabis was placed in a container and heated to 105 ℃ to perform decarboxylation.
[0058] Preparation Examples 10 to 18. 120 ℃
[0059] The dried and ground cannabis was placed in a container and heated to 120°C to perform decarboxylation.
[0061] Preparation Examples 19 to 27. 150 ℃
[0062] The dried and ground cannabis was placed in a container and heated to 150°C to perform decarboxylation.
[0064] <Test Example I>
[0065] The results of this experiment were analyzed using the statistical program Grahpad Prism (ver. 6, San Diego, California, USA), and the measurement results of each experimental item were expressed as mean ± standard deviation (mean ± SD). Mean differences between groups were confirmed using one-way ANOVA, and statistical significance was determined by conducting the Tukey test. P<0.05 It was tested at the level.
[0066] Test Example 1. Measurement of Cannabidiol (CBD) Conversion Rate
[0067] The conversion rate of cannabidiol acid (CBDA) to cannabidiol (CBD) through decarboxylation was measured. * Significance between temperatures at the same treatment time was confirmed (p < 0.05).
[0068] The conversion rate was determined through HPLC (High Performance Liquid Chromatography) analysis.
[0069] [Mathematical Formula 1]
[0070] CBD Conversion Rate (%) = 100 * (Current CBD Content) / {(Initial CBD Content) + (Initial CBDA Content)}
[0071] division CBD content (%) CBDA content (%) CBD Conversion Rate (%) Preparation Example 1 105 ℃ 0 minutes 6.90±0.27 3.13±0.13 68.81±2.67 Preparation Example 2 30 minutes 7.18±0.36 3.20±0.25 71.59±3.60 Preparation Example 3 60 minutes 7.46±0.17 2.90±0.14 74.37±1.67 Preparation Example 4 90 minutes 7.22±0.10 2.16±0.05 * 72.02±1.03 Preparation Example 5 120 minutes 7.96±0.39 2.32±0.06 * 79.41±3.88 Preparation Example 6 150 minutes 8.24±0.09 2.06±0.05 ** 82.24±0.86 Preparation Example 7 180 minutes 8.61±0.05 1.86±0.05 ** 85.92±0.47 Preparation Example 8 210 minutes 8.34±0.13 1.54±0.02 *** 83.18±1.25 Preparation Example 9 240 minutes 8.93±0.65 * 1.43±0.13 *** 89.08±6.50 * Preparation Example 10 120 ℃ 0 minutes 6.90±0.27 3.13±0.13 68.81±2.67 Preparation Example 11 30 minutes 6.86±0.37 2.95±0.18 * 68.44±3.71 Preparation Example 12 60 minutes 7.58±0.41 2.47±0.12 *** 75.56±4.12 Preparation Example 13 90 minutes 8.26±0.19 1.73±0.00 *** 82.39±1.93 Preparation Example 14 120 minutes 8.58±0.45 1.36±0.05 *** 85.53±4.50 Preparation Example 15 150 minutes 10.24±0.27 ** 1.30±0.08 *** 102.15±2.72 * Preparation Example 16 180 minutes 9.05±0.79 0.81±0.09 *** 90.30±7.90 Preparation Example 17 210 minutes 9.18±0.36 0.71±0.04 *** 91.52±3.63 Preparation Example 18 240 minutes 8.71±0.27 0.54±0.02 *** 86.83±2.70 Preparation Example 19 150 ℃ 0 minutes 6.90±0.27 3.13±0.13 68.81±2.67 Preparation Example 20 30 minutes 7.25±0.03 2.98±0.00 72.30±0.29 Preparation Example 21 60 minutes 8.01±0.37 2.05±0.06 *** 79.92±3.67 Preparation Example 22 90 minutes 9.10±0.35 ** 0.90±0.06 *** 90.77±3.47 ** Preparation Example 23 120 minutes 9.34±0.15 *** 0.27±0.03 *** 93.15±1.51 *** Preparation Example 24 150 minutes 8.15±0.05 * 0.04±0.01 *** 81.26±0.50 * Preparation Example 25 180 minutes 7.87±0.06 0.00±0.00 *** 78.48±0.61 Preparation Example 26 210 minutes 7.09±0.02 0.00±0.00 *** 70.75±0.22 Preparation Example 27 240 minutes 5.80±0.13 0.00±0.00 *** 57.81±1.25
[0072] As shown in Table 1 above, the conversion rate was less than 90% up to 240 minutes at 105 ℃, and it was confirmed that the conversion rate was excellent at 150 minutes (102.15%) at 120 ℃ and at 120 minutes (93.15%) at 150 ℃.
[0073] In the case of 150 ℃, it was confirmed that decomposition occurred during the process of conversion to cannabidiol by heating, causing the conversion rate to decrease rapidly.
[0074] Accordingly, the following test was performed using conditions of 120°C and 150 minutes, which yielded the best conversion rate.
[0076] [Measurement of Cannabidiol (CBD) Extraction Efficiency]
[0077] Example 1.
[0078] Dried and ground cannabis was placed in a container and heated to 120°C for 150 minutes to obtain decarboxylated cannabis, and then extracted for 6 hours using a 10L supercritical fluid extraction device (POSENTECH) at 50°C with carbon dioxide (no auxiliary solvent used) while varying the pressure conditions. As shown in Fig. 1, the pressure conditions were as follows: the pressure was maintained at 100 bar for 60 minutes, then increased from 100 bar at a rate of 3.3 bar / min for 30 minutes to reach 200 bar, then decreased from 200 bar to 100 bar within 1 second (1 cycle), and once 100 bar was reached, the pressure was maintained for 60 minutes, and then increased back to 200 bar; this process was repeated for a total of 6 hours to obtain the extract. That is, after repeating the above cycle three times and reaching 100 bar, the pressure was maintained for 60 minutes and then increased again to 200 bar, thereby completing the extraction.
[0080] Comparative Example 1. 100 bar
[0081] Dried and ground cannabis was placed in a container and heated to 120°C for 150 minutes to obtain decarboxylated cannabis, and then extracted at 50°C and 100 bar for 6 hours under carbon dioxide (without using an auxiliary solvent) using a 10L supercritical fluid extraction device (POSENTECH) to obtain an extract.
[0083] Comparative Example 2. 200 bar
[0084] The above Comparative Example 1 was carried out in the same manner, but the extract was obtained by extracting at 200 bar for 6 hours instead of 100 bar.
[0086] Comparative Example 3. 300 bar
[0087] The above Comparative Example 1 was carried out in the same manner, but the extract was obtained by extracting at 300 bar for 6 hours instead of 100 bar.
[0089] <Test Example II>
[0090] The results of this experiment were analyzed using the statistical program Grahpad Prism (ver. 6, San Diego, California, USA), and the measurement results of each experimental item were expressed as mean ± standard deviation (mean ± SD). Mean differences between groups were confirmed using one-way ANOVA, and statistical significance was determined by conducting the Tukey test. P<0.05 It was tested at the level.
[0091] Test Example 2. Measurement of Cannabidiol (CBD) Extraction Rate, etc.
[0092] The cannabidiol (CBD) content, purity, and extraction rate in the extracts prepared according to Example 1 and Comparative Examples 1 to 3 were measured. * Significance between each group was confirmed (p < 0.05).
[0093] The cannabidiol (CBD) content, purity, and extraction rate were measured using HPLC (High Performance Liquid Chromatography). The column used was a Luna C18(2) Column (150 X 4.60 mm id, 3 μm Particle Size, Phenomenex, USA). The column temperature was maintained at 28 ℃, the flow rate at 1.2 mL / min, and the sample was injected at a rate of 5 μL. Detection of sample components was performed using a Diode Array Detector (DAD) at 220 nm. Mobile phase A was a 0.1% aqueous formic acid solution, and mobile phase B was a 0.1% formic acid-containing acetonitrile; analysis was performed under Gradient conditions as shown in [Table 2] below. A calibration curve was constructed using the peak areas on the chromatogram with the calibration curve standard solutions, and the CBD and THC content in the sample was quantified using the constructed calibration curve.
[0094] Time (min) Mobile phase A * (vol%) Mobile phase B † (vol%) 0 30 70 6 30 70 12 23 77 22 23 77 22.2 30 70 26 30 70 * 0.1% Formic acid in water, †0.1% Formic acid in acetonitrile
[0095] delete
[0096] division Example 1 Comparative Example 1 Comparative Example 2 Comparative Example 3 Extraction yield (%) 9.2 2.8 10.5 10.8 CBD yield (%) after extraction 4.4±0.03 b 1.3±0.02 c 4.8±0.07 a 4.6±0.02 a CBD Purity (Content, %) 83.5±0.02 b 87.4±0.04 a 82.8±0.18 c 82.9±0.09 c CBD extraction rate (%) 71.1±0.59 a 19.2±0.31 c 70.4±1.08 ab 68.6±0.37 b As shown in Table 3 above, it was confirmed that the extract prepared according to Example 1 of the present invention had a higher content and extraction rate of cannabidiol (CBD) in the extract compared to Comparative Examples 1 to 3.
[0097] delete
[0098] On the other hand, Comparative Example 1 showed very low extraction yield, cannabidiol (CBD) content in the extract, and extraction rate, while Comparative Example 3 showed low cannabidiol (CBD) content and extraction rate in the extract.
[0100] Test Example 3. Confirmation of impurities in the extract
[0101] To measure the impurities contained in the extracts prepared according to Example 1 and Comparative Examples 1 to 3, the absorbance of impurities at wavelengths of 400 to 700 nm was checked using a spectrophotometer, and the absorbance values of impurities at a wavelength of 450 nm were compared.
[0102] FIG. 2 is a graph showing the results of measuring the extracts prepared according to Example 1 and Comparative Examples 1 to 3 of the present invention using a spectrophotometer.
[0103] Table 4 below shows the absorbance values of impurities at 400 to 500 nm, particularly at 450 nm, which were identified as absorbing substances in Figure 2 above, and photographs of the extracts accordingly.
[0104] The following chromatography (Medium Pressure Liquid Chromatography) is the extract prepared in Comparative Example 2 purified by chromatography.
[0105]
[0106] As shown in Figure 2 and Table 4, it was confirmed that the absorbance value of the extract prepared according to Example 1 of the present invention is similar to Comparative Example 1 and lower than that of Comparative Examples 2 and 3.
[0107] A higher absorbance value indicates a higher content of impurities, and accordingly, it appears dark brown; thus, the extract of Example 1 appears light brown and has a low absorbance value, confirming that the content of impurities in the extract is low.
[0108] In addition, it was confirmed that the extract of Example 1 of the present invention has a low impurity content even without performing a purification process.
[0110] When combining the results of Test Examples 2 and 3 above, Comparative Example 1 has a low content of impurities in the extract but a very low extraction yield, cannabidiol (CBD) content, and extraction rate; Comparative Example 2 has a relatively good cannabidiol (CBD) content and extraction rate but a high content of impurities; and Comparative Example 3 has a low cannabidiol (CBD) content and extraction rate and a high content of impurities. Therefore, it was confirmed that Example 1, which has a high cannabidiol (CBD) content and extraction rate and a low content of impurities, is the most superior.
[0112] Test Example 4. Measurement of purity after crystallization
[0113] Ethanol was added in tenfold amounts (weight ratio of 1:10) to each extract prepared according to Example 1 and Comparative Examples 1 to 3, and the mixture was left at -80°C for 24 hours. The resulting precipitate was filtered through filter paper to obtain a dewaxed extract. The dewaxed extract was concentrated using a rotary vacuum concentrator to remove the ethanol, then 1 to 1.5 times the amount of pentane was added and completely dissolved at 40°C, followed by stirring while maintaining at 5°C for 30 minutes. Next, the mixture was stirred while maintaining at 0°C for 15 minutes, then the temperature was lowered to -10°C over 60 minutes, and crystallization was performed by stirring at -10°C for 30 minutes.
[0114] Figure 3 is a chromatogram showing the purity of cannabidiol after crystallization of the extracts prepared according to Example 1 and Comparative Examples 1 to 3.
[0115] division Example 1 Comparative Example 1 Comparative Example 2 Comparative Example 3 Crystallization recovery rate (%) 49.03±0.56 a 52.93±0.88 a 31.73±0.34 c 25.44±0.45 c CBD Isolate purity(%) 100 100 100 100 As shown in Figure 3 and Table 5 above, it was confirmed that the cannabidiol purity of the extracts prepared according to Example 1 and Comparative Examples 1 to 3 after crystallization was 100%.
[0116] delete
[0118] division Example 1 Comparative Example 1 Comparative Example 2 Comparative Example 3 CBD yield (%) after extraction 4.4±0.1 a 1.3±0.1 c 4.8±0.4 a 4.6±0.3 a CBD yield (%) after dewaxing 3.5±0.1 a 1.2±0.2 c 3.5±0.2 a 3.8±0.5 a CBD yield (%) after crystallization 1.72±0.2 a 0.63±0.1 c 1.11±0.1 b 0.96±0.2 b As shown in Table 6 above, it was confirmed that the yield of the final crystallized cannabidiol from the hemp raw material was obtained at a higher yield in Example 1 compared to Comparative Example 1, Comparative Example 2, and Comparative Example 3.
[0119] delete
Claims
Claim 1 (A) a step of decarboxylating cannabis; and (B) a step of extracting the decarboxylated cannabis, including a process of increasing the pressure from 100 bar to 200 bar using a supercritical fluid at 50 ℃ and then decreasing the pressure from 200 bar to 100 bar; wherein the extraction under the supercritical fluid in step (B) comprises: (a) a step of maintaining at 100 bar for 50 to 80 minutes; (b) a step of increasing the pressure maintained at 100 bar to 200 bar; and (c) a step of decreasing the pressure to 100 bar once the increased pressure reaches 200 bar. and (d) a step of reducing the pressure to 100 bar, maintaining it for 50 to 80 minutes, and then increasing the pressure again to 200 bar; the step is repeated for 4 to 8 hours, and the supercritical fluid is supercritical carbon dioxide, characterized in that the method for obtaining cannabidiol from hemp. Claim 2 A method for obtaining cannabidiol from hemp according to claim 1, characterized in that, in step (A), decarboxylation is performed at 100 to 150 ℃ for 120 to 240 minutes. Claim 3 A method for obtaining cannabidiol from hemp according to claim 1, characterized in that, in step (A), decarboxylation is performed at 115 to 130 ℃ for 140 to 240 minutes. Claim 4 delete Claim 5 A method for obtaining cannabidiol from cannabis according to claim 1, characterized in that the pressure increase in step (B) is performed at a rate of 2 to 5 bar / min. Claim 6 A method for obtaining cannabidiol from cannabis according to claim 1, characterized in that in step (B), the pressure is lowered immediately from 200 bar to 100 bar within 10 seconds. Claim 7 A method for obtaining cannabidiol from cannabis according to claim 1, characterized in that the pressure increase in step (B) is performed for 30 to 40 minutes. Claim 8 delete Claim 9 delete Claim 10 A method for obtaining cannabidiol from cannabis according to claim 1, characterized by adding, after step (B), (C) a step of dewaxing the extract obtained with the supercritical fluid; and (D) a step of crystallizing the dewaxed extract to obtain cannabidiol. Claim 11 A method for obtaining cannabidiol from hemp, characterized in that, in claim 10, the purity of the crystallized cannabidiol is 99.0 to 100%.
Citation Information
Patent Citations
Method for preparing high-purity CBD on large scale through cooperation of post-decarboxylation and supercritical extraction
CN112661612A
